Tampa Florida (PRWEB) July 11, 2012
“Two roads diverged in a wood, and I —I took the one less traveled by, and that has made all the difference.” – Robert Frost
It is an unusual statement to the press which begins with a telemedicine company Founder quoting the American poet Robert Frost, but Thomas Meehan has never been one to “color within the lines.” Meehan, the Founder of the “talk to a doctor” hotline MD247, issued a press release on July 10, 2012 ushering in a change to a “road less traveled” for the company on LiveJournal.
Meehan explained that course correction, or even charting new waters, has been a practice on the MD247 LiveJournal business page since the beginning. Finding a voice in and amongst the 5,000 “web everything” doctor sites is a difficult task and, in order to step out of the shadow, Meehan made the unprecedented move of changing his “social media channel” to “all talk.” This translates to MD247 existing as one of a select few LiveJournal accounts encouraging real open discussion regarding current political and economic topics.
The MD247 Social Media Curator, Michelle Germann, has been given the “green light” to allow polite discussion of topics like national healthcare; the election and the realities of national unemployment rates. Germann advised that conservatives, liberals, independents, libertarians and all other interested individuals are welcome to conduct polite discussion.
Largo Florida based MD247.COM (MD247; MD/247; MD 247; M.D.247; MD-247) provides an affordable telemedicine supplement to existing healthcare services. MD247.COM telemedicine program members have unlimited telephone access to a nationwide medical support team, all with just a single phone call to the MD247.COM telemedicine Talk to a Tampa Doctor/Talk to a Nurse Hotline. MD247.COM has a virtual platoon of registered nurses; board certified physicians and a support staff available to members for all non-emergency situations. More information about MD247.COM is available online at http://www.md247.com.
Read the full story at http://www.prweb.com/releases/2012/7/prweb9692616.htm
